Development of Biomarker for the Evaluation of Response After Neoadjuvant Therapy in Patients With Pancreatic Cancer

NCT04110769 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Genetic Change
Chemotherapy Effect
Pancreatic Cancer

Interventions

DIAGNOSTIC_TEST: next generation sequencing
DIAGNOSTIC_TEST: following next generation sequencing

Sponsor

Asan Medical Center